Evidence map›Paper›PMID 25794620›Full record

ArticleMolecular cell2015

TopBP1 interacts with BLM to maintain genome stability but is dispensable for preventing BLM degradation.

Andrew N Blackford, Jadwiga Nieminuszczy, Rebekka A Schwab, Yaron Galanty, Stephen P Jackson, Wojciech Niedzwiedz

Open access · hybridAbstract read
In one paragraph

Article in Molecular cell, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 79 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Pre-rRNA Facilitates TopBP1-Mediated DNA Double-Strand Break Response.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2023
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Andrew N BlackfordThe Weatherall Institute of Molecular Medicine, University of Oxford, Oxford OX3 9DS, UK; The Gurdon Institute and Department of Biochemistry, University of Cambridge, Cambridge CB2 1QN, UK.
Jadwiga NieminuszczyThe Weatherall Institute of Molecular Medicine, University of Oxford, Oxford OX3 9DS, UK; Institute of Biochemistry and Biophysics, PAS, 02-106 Warsaw, Poland.
Rebekka A SchwabThe Weatherall Institute of Molecular Medicine, University of Oxford, Oxford OX3 9DS, UK.
Yaron GalantyThe Gurdon Institute and Department of Biochemistry, University of Cambridge, Cambridge CB2 1QN, UK.
Stephen P JacksonThe Gurdon Institute and Department of Biochemistry, University of Cambridge, Cambridge CB2 1QN, UK; The Wellcome Trust Sanger Institute, Hinxton, Cambridge CB10 1SA, UK. Electronic address: s.jackson@gurdon.cam.ac.uk.
Wojciech NiedzwiedzThe Weatherall Institute of Molecular Medicine, University of Oxford, Oxford OX3 9DS, UK. Electronic address: wojciech.niedzwiedz@imm.ox.ac.uk.
MRC Weatherall Institute of Molecular Medicine · GBUniversity of Oxford · GBWellcome/Cancer Research UK Gurdon Institute · GB

Funding

Cancer Research UK 11224Cancer Research UK 18796Cancer Research UK C6946/A14492Cancer Research UK C6/A11224Medical Research Council G0902418Wellcome Trust WT092096Worldwide Cancer Research 07-0922
6 · The paper itself

Abstract

The Bloom syndrome helicase BLM and topoisomerase-IIβ-binding protein 1 (TopBP1) are key regulators of genome stability. It was recently proposed that BLM phosphorylation on Ser338 mediates its interaction with TopBP1, to protect BLM from ubiquitylation and degradation (Wang et al., 2013). Here, we show that the BLM-TopBP1 interaction does not involve Ser338 but instead requires BLM phosphorylation on Ser304. Furthermore, we establish that disrupting this interaction does not markedly affect BLM stability. However, BLM-TopBP1 binding is important for maintaining genome integrity, because in its absence cells display increased sister chromatid exchanges, replication origin firing and chromosomal aberrations. Therefore, the BLM-TopBP1 interaction maintains genome stability not by controlling BLM protein levels, but via another as-yet undetermined mechanism. Finally, we identify critical residues that mediate interactions between TopBP1 and MDC1, and between BLM and TOP3A/RMI1/RMI2. Taken together, our findings provide molecular insights into a key tumor suppressor and genome stability network.

Indexed as

Genomic InstabilityAdaptor Proteins, Signal TransducingAmino Acid SequenceCarrier ProteinsCell Cycle ProteinsDNA-Binding ProteinsDNA Topoisomerases, Type IHeLa CellsHumansMolecular Sequence DataMutationNuclear ProteinsPhosphorylationRecQ HelicasesSerineTrans-ActivatorsAdaptor Proteins, Signal TransducingBloom syndrome proteinCarrier ProteinsCell Cycle ProteinsDNA-Binding ProteinsDNA Topoisomerases, Type IMDC1 protein, humanNuclear ProteinsRecQ HelicasesRMI1 protein, humanRMI2 protein, humanSerineTOPBP1 protein, humanTrans-Activators

Identifiers

PMID25794620
PMCPMC4374139
OpenAlexW2091477675

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.